Grapefruit USA (Grapefruit USA) Capex-to-Revenue : 0.00 (As of Sep. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Grapefruit USA Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Grapefruit USA's Capital Expenditure for the three months ended in Sep. 2023 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2023 was $0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.

Grapefruit USA Capex-to-Revenue Historical Data

The historical data trend for Grapefruit USA's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grapefruit USA Capex-to-Revenue Chart

Grapefruit USA Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Capex-to-Revenue

Get a 7-Day Free Trial

0.69

0.01

0.11

Grapefruit USA Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Sep23
Capex-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Grapefruit USA's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Grapefruit USA's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grapefruit USA's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grapefruit USA's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Grapefruit USA's Capex-to-Revenue falls into.

Grapefruit USA Capex-to-Revenue Calculation

Grapefruit USA's Capex-to-Revenue for the fiscal year that ended in Dec. 2021 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-0.062)	/	0.589
	=	0.11

Grapefruit USA's Capex-to-Revenue for the quarter that ended in Sep. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (0)	/	0
	=	N/A

Grapefruit USA (OTCPK:GPFT) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Grapefruit USA Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Grapefruit USA's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Grapefruit USA (Grapefruit USA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grapefruit USA Inc (OTCPK:GPFT) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

10866 Wilshire Boulevard, Suite 225, Los Angeles, CA, USA, 90024

Website

https://grapefruitblvd.com

Grapefruit USA Inc manufactures and distributes cannabis-based products. Its extraction lab produces high-quality distillate or Honey Oil from trim that Grapefruit sources through its Distribution arm. The company is a premier licensed Distributor of all things cannabis throughout the State of California. It serves licensed Medicinal and Recreational Dispensaries. Its patented product is Hourglass Cream. Grapefruit owns and operates a California-licensed cannabis extraction laboratory and wholesale distribution facility in the Coachillin' Canna-Business Park near Palm Springs, California.

Executives

Bradley J Yourist	director, 10 percent owner, officer: Chairman and CEO	10866 WILSHIRE BLVD, #225, LOS ANGELES CA 90024
Daniel J. Yourist	director, 10 percent owner, officer: Board of Directors and COO	10866 WILSHIRE BLVD, SUITE 225, LOS ANGELES CA 90024
Dane Medley	director, officer: CEO/Chairman	10553 CAMARILLO STREET, TOLUCA LAKE CA 91602
Emilio Xavier Aguilera	director, officer: Chief Financial Officer	16827 HALSEY STREET, GRANADA HILLS CA 91344
Dean Janes	officer: CHIEF EXECUTIVE OFFICER	3200 W. VALHALLA DRIVE, BURBANK CA 91505
Christopher Sohn	director, officer: President and COO	3200 W. VALHALLA DRIVE, BURBANK CA 91505
Xavier Aguilera	director, officer: CFO/Treasurer,Exec.V.P.& Secy	3200 W. VALHALLA DRIVE, BURBANK CA 91505
Michele Janes	officer: Vice President of Admin.	3200 W. VALHALLA DRIVE, BURBANK CA 91505